AHA 2022 Debate: Should CABG Be Level IIB for Improving Survival Compared to Medical Therapy in Three-Vessel CAD With Normal Left Ventricular Function? - No | VuMedi

AHA 2022 Conference Coverage

AHA 2022 Debate: Should CABG Be Level IIB for Improving Survival Compared to Medical Therapy in Three-Vessel CAD With Normal Left Ventricular Function? - No

By AHA 2022 Conference Coverage FEATURING Faisal Bakaeen

By AHA 2022 Conference Coverage FEATURING Faisal Bakaeen

303 views

November 29, 2022

Comments 0

Login to view comments. Click here to Login